Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117151) titled 'Construction and Validation of a Risk Prediction Model for Adverse Reactions to Subcutaneous Immunotherapy for House Dust Mites in Children' on Jan. 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Children's Hospital,Zhejiang University School of Medicine
Condition:
Systemic adverse reactions during subcutaneous specific immunotherapy for dust mite-induced allergic diseases in children, such as allergic asthma and allergic rhinitis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: Observation group:500;
Countries of ...